Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00129207 · ClinicalTrials.gov registry record · Phase 1
Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade
A Phase 1 study, sponsored by Millennium Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00129207: Completed Phase 1 study, sponsored by Millennium Pharmaceuticals.
NCT00129207 is a Phase 1 study that has completed, run by Millennium Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00129207, a Phase 1 study, has completed, sponsored by Millennium Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to investigate how ketoconazole (Nizoral) affects the pharmacokinetics (how the study drug is affected by the body and broken down) and pharmacodynamics (how the study drug acts on the body) of the active ingredient in the study drug Velcade (bortezomib).
Interventions
- DRUG bortezomib
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00129207 record still lists
NCT00129207 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which bortezomib is the first listed.
NCT00129207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00129207 about?
NCT00129207 is a clinical study titled "Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade". The purpose of this study is to investigate how ketoconazole (Nizoral) affects the pharmacokinetics (how the study drug is affected by the body and broken down) and pharmacodynamics (how the study drug acts on the body) of the active ingredient in the study drug Velcade (bortezomib).
What is the current status of trial NCT00129207?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00129207?
The interventions under investigation include: bortezomib (DRUG).
Who is sponsoring clinical trial NCT00129207?
This trial is sponsored by Millennium Pharmaceuticals, which has 135 total clinical trials registered on ClinicalTrials.gov.